, Volume 168, Supplement 1, pp 379–387 | Cite as

Development of local immunity: Role in mechanisms of protection against or pathogenesis of respiratory syncytial viral infections

  • David Nadal
  • Pearay L. Ogra
Viral Bronchiolitis In Infancy


The bronchus associated lymphoid tissue (BALT) and the precursor immunocompetent lymphoid cells in the nasopharynx, tonsils, and salivary glands represent the basic source of specific secretory IgA, other immunoglobulin, and T cell mediated specific immunity in the respiratory tract. The bulk of this immunologic reactivity is derived largely from BALT, and via the migration of antigen-sensitized immunocompetent cells, from the gut associated lymphoid tissues (GALT). Recent investigations have suggested that mechanisms underlying the development of virus-induced bronchopulmonary diseases, notably bronchospasm, include host factors such as altered immune response with persistent virus-specific IgE and IgG4 antibody responses in the respiratory tract, the appearance of specific immune complexes, and development of exaggerated immune response to other environmental agents and dietary proteins. In addition, pathogen related factors responsible for direct tissue damage during infection also play an important role.

Key words

Respiratory syncytial viral infections Bronchopulmonary diseases IgE and IgG4 antibody responses 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Bienenstock J (1984) Immunology of the lung and upper respiratory tract. New York: McGraw-HillGoogle Scholar
  2. 2.
    Chiba Y, Higashidate Y, Suga K, et al (1989) Development of cell-mediated cytotoxic immunity to respiratory synctial virus in human infants following naturally acquired infection. J Med Virol 28:133–139PubMedCrossRefGoogle Scholar
  3. 3.
    Cloutier M, Wong D, Ogra PL (1989) Respiratory syncytial virus exhibits ion transport in cotton rat epithelium. Pediatr Pulmonol 6:164–168PubMedCrossRefGoogle Scholar
  4. 4.
    Faden H, Kaul TN, Ogra PL (1983) Activation of oxidative and arachidonic acid metabolism in neutrophils by respiratory syncytial virus antibody complexes: possible role in disease. J Infect Dis 148:110–116PubMedGoogle Scholar
  5. 5.
    Fishaut M, Tubergen D, McIntosh H (1980) Cellular immune response to respiratory viruses with particular reference to children with disorders of cell-mediated immunity. J Pediatr 96:179–186PubMedCrossRefGoogle Scholar
  6. 6.
    Freihorst J, Piedra PA, Okamoto Y, Ogra PL (1988) Effect of respiratory syncytial virus on the uptake of an immune response to other inhaled antigens. Proc Soc Exp Biol Med 188:191–197PubMedGoogle Scholar
  7. 7.
    Frick DL, German DF, Mills J (1979) Development of allergy in children. I. Association with virus infections. J Allergy Clin Immunol 63:228–241PubMedCrossRefGoogle Scholar
  8. 8.
    Glezen WP, Denny FW (1973) Epidemiology of acute lower respiratory tract disease in children. N Engl J Med 288:498–505PubMedCrossRefGoogle Scholar
  9. 9.
    Glezen WP, Paredas A, Allison JE, Taber LH, Frank AL Risk of respiratory syncytial virus infection for infants from low-income families in relationship to age, sex, etnic group, and maternal antibody level. J Pediatr 98:708–715Google Scholar
  10. 10.
    Hall CB, Powell KR, MacDonald NE, Gala CL, Menegus ME, Suffin SC, Cohen HJ (1986) Respiratory syncytial viral infection in children with compromised immune function. N Engl J Med 315:77–81PubMedCrossRefGoogle Scholar
  11. 11.
    Hanson LÅ, Brandtzeg P (1989) The mucosal defense system. In: Stiehm ER, ed. Immunologic disorders in infants and children. Philadelphia: Saunders WB, 116–155Google Scholar
  12. 12.
    Kapikian AZ, Mitchell RH, Chanock RM, Shvedoff RA, Stewart CE (1969) An epidemiologic study of altered clinical reactivity to respiratory syncytial (RS) virus infection in children previously vaccinated with an inactivated RS virus vaccine. Am J Epidemiol 89:405–421PubMedGoogle Scholar
  13. 13.
    Kaul TN, Welliver RC, Wong DT, Udwadia RA, Riddlesberger K, Ogra PL (1981) Secretory antibody response to respiratory syncytial virus infection Am J Dis Child 135:1013–1016PubMedGoogle Scholar
  14. 14.
    Kim HW, Leikin SL, Arrobio J, Brandt CD, Channock RM, Parrot RH (1976) Pediatr Res 10:75–78PubMedCrossRefGoogle Scholar
  15. 15.
    Leibovitz E, Freihorst, Piedra PA, Ogra PL (1988) Modulation of systemic and mucosal immune responses to inhaled ragweed antigen in experimentally induced infection with respiratory syncytial virus implication in virally induced allergy. Int Arch Allergy Appl Immun 86:112–116Google Scholar
  16. 16.
    McIntosh K, Ellis EF, Hoffmann LS, Lybas TG, Eller JJ, Fulginiti VA (1973) The association of viral and bacterial respiratory infections with exacerbations of wheezing in young asthmatic children. J Pediatr 82:578–590PubMedCrossRefGoogle Scholar
  17. 17.
    McIntosh K, Masters HB, Orr I, Chao RK, Barkin RM (1978) The immunologic response to infection with respiratory syncytial virus in infants. J Infect Dis 138:24–32PubMedGoogle Scholar
  18. 18.
    Mills JV, VanKirk JE, Wright PF, Chanock RM (1971) Experimental respiratory viral infection of adults. J Immunol 107:123–130PubMedGoogle Scholar
  19. 19.
    Milner ME, de la Monte SM, Hutchins GM (1985) Fatal respiratory syncytial virus infection in severe combined immunodeficiency syndrome. AJDC 139:1111–1114PubMedGoogle Scholar
  20. 20.
    Ogra PL, Kerr-Grant D, Umana G, et al (1968) Antibody response in serum and secretions after immunization with live and inactivated poliovaccine and natural infection. N Engl J Med 279:893–900CrossRefPubMedGoogle Scholar
  21. 21.
    Ogra PL, Welliver RC, Riepenhoff-Talty M, Faden HS (1984) Interaction of mucosal immune system and infections in infancy: implications in allergy. Ann Allergy 53:523–534PubMedGoogle Scholar
  22. 22.
    Scott R, Kaul A, Scott M, Chiba Y, Ogra PL (1978) Development of in vitro correlates of cell-mediated immunity to respiratory syncytial virus infection in humans. J Infect Dis 137:810–817PubMedGoogle Scholar
  23. 23.
    Volovitz B, Welliver Rc, DeCastro G, Krystofik DA, Ogra PL (1988) The release of leukotrienes in the respiratory tract during infection with respiratory syncytial virus: role in obstructive airway disease. Pediatr Res 24:504–507PubMedCrossRefGoogle Scholar
  24. 24.
    Volovitz B, Faden H, Ogra PL (1988) Release of leukotriene C4 in respiratory tract during acute viral infection. J Pediatr 112:218–222PubMedCrossRefGoogle Scholar
  25. 25.
    Welliver RC, Kaul A, Ogra PL (1979) Cell-mediated immune response to respiratory syncytial virus infection: relationship to the development of reactive airway disease. J Pediatr 94:370–375PubMedCrossRefGoogle Scholar
  26. 26.
    Welliver RC, Kaul NT, Ogra PL (1980) The appearance of cell-bound IgE in respiratory-tract epithelium after respiratory-syncytial-virus infection. N Engl J Med 303:1198–1202PubMedCrossRefGoogle Scholar
  27. 27.
    Welliver RC, Kaul NT, Putnam TI, Sun M, Riddlesberger K, Ogra PL (1980) The antibody response to primary and secondary infection with respiratory syncytial virus: kinetics of class specific responses. J Pediatr 96:806–813Google Scholar
  28. 28.
    Welliver RC, Wong DT, Sun M, Middleton E Jr, Vaughan RS, Ogra PL (1981) The development of respiratory syncytial virus-specific IgE and the release of histamine in nasopharyngeal secretions after infection. N Engl J Med 305:841–846PubMedCrossRefGoogle Scholar
  29. 29.
    Welliver RC, Kaul TM, Sun M, Ogra PL (1984) Defective regulation of immune responses in respiratory syncytial virus infection. J Immunol 133:1925–1930PubMedGoogle Scholar

Copyright information

© Springer-Verlag New York Inc 1990

Authors and Affiliations

  • David Nadal
    • 1
    • 2
  • Pearay L. Ogra
    • 1
  1. 1.Departments of Pediatrics and MicrobiologyState University of New York at Buffalo School of MedicineUSA
  2. 2.Division of Infectious DiseasesChildren’s HospitalBuffaloUSA

Personalised recommendations